Target intelligence / Profile preview

RNA, U4 small nuclear 63, pseudogene (RNU4-63P)

Target
RNU4-63P
Molecular classification
Pseudogene, non-coding RNA, small nuclear RNA pseudogene
01

Overview

RNU4-63P is a non-coding RNA gene annotated as a pseudogene corresponding to the U4 small nuclear RNA family, which normally plays a role as an RNA component of the major spliceosome. However, as a pseudogene, RNU4-63P does not encode a functional small nuclear RNA and is not known to have a biological role or disease association[1][5][7]. RNU4-63P is not a protein, enzyme, receptor, or other canonical drug target; it is listed as a pseudogene—meaning it does not produce a functional product[1][7]. There is no evidence for any biological or clinical function, nor established roles in disease, biomarkers, or known drug interactions for this specific pseudogene[1][7][6]. Pseudogenes like RNU4-63P are typically non-functional copies of genes and rarely serve as therapeutic targets. It is important not to confuse RNU4-63P with functional U4 snRNA genes (such as RNU4-2), which are known to play roles in RNA splicing and may be implicated in neurodevelopmental disorders, but RNU4-63P is not among these functional variants[1][2][3].

Other names
RNU4-63PRNA, U4 small nuclear 63, pseudogene

Beyond the preview

Go deeper on RNA, U4 small nuclear 63, pseudogene (RNU4-63P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U4 small nuclear 63, pseudogene (RNU4-63P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call